The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019
- PMID: 36403049
- PMCID: PMC9675283
- DOI: 10.1186/s12931-022-02242-z
The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease that is characterised by persistent respiratory symptoms and airflow limitation. The present study reported the burden of COPD, and its attributable risk factors, in the Middle East and North Africa (MENA) region between 1990 and 2019, by age, sex and socio-demographic index (SDI).
Methods: Data from the Global Burden of Disease (GBD) 2019 study were used to report the burden of COPD in the MENA countries. The prevalence, deaths, and disability-adjusted life-years (DALYs) were presented as counts and age-standardised rates per 100,000 population, with their associated 95% uncertainty intervals (UIs).
Results: In 2019, the regional age-standardised point prevalence and rates of death due to COPD were 2333.9 (2230.1, 2443.6) and 26.1 (22.2, 29.5) per 100,000, which represent a 30.6% (28.2%, 33.0%) increase and an 18.0% (2.8%, 30.9%) decrease, respectively, since 1990. The regional age-standardised DALY rate in 2019 was 649.1 (574.6, 717.7) per 100,000, which had decreased by 11.8% (0.9%, 21.1%) since 1990. Turkey had the highest age-standardised point prevalence in 2019 [3287.1 (3187.4, 3380.3)], while Afghanistan had the highest age-standardised death [40.4 (24.2, 52.6)] and DALY [964.5 (681.8, 1203.2)] rates. The regional age-standardised point prevalence, death and DALY rates in 2019 increased with advancing age and were higher in males in almost all age groups. There was a U-shaped association between SDI and the burden of COPD over the period 1990 to 2019. Moreover, in 2019 smoking (43.7%), ambient particulate matter pollution (22.8%) and occupational particulate matter (11.4%) had the largest proportion of attributable DALYs for both sexes.
Conclusions: COPD is one of the leading causes of death and disability in the MENA region, although the age-standardised burden has decreased over the last 30 years. Nevertheless, COPD accounted for a substantial number of deaths and DALYs, especially among the elderly. Programs targeting risk factors, like smoking, should be taken into consideration.
Keywords: Chronic obstructive pulmonary disease; Epidemiology; Global burden of disease; Middle East and North Africa; Risk factor; Socio-demographic index.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16. Lancet Respir Med. 2017. PMID: 28822787 Free PMC article.
-
The burden of lower respiratory infections and their underlying etiologies in the Middle East and North Africa region, 1990-2019: results from the Global Burden of Disease Study 2019.BMC Pulm Med. 2023 Jan 4;23(1):2. doi: 10.1186/s12890-022-02301-7. BMC Pulm Med. 2023. PMID: 36600241 Free PMC article.
-
The burden of stroke and its attributable risk factors in the Middle East and North Africa region, 1990-2019.Sci Rep. 2022 Feb 17;12(1):2700. doi: 10.1038/s41598-022-06418-x. Sci Rep. 2022. PMID: 35177688 Free PMC article.
-
Cardiovascular disease burden in the Middle East and North Africa region.Curr Probl Cardiol. 2024 Mar;49(3):102341. doi: 10.1016/j.cpcardiol.2023.102341. Epub 2023 Dec 14. Curr Probl Cardiol. 2024. PMID: 38103814 Review.
-
Burden of colorectal cancer and its risk factors in the North Africa and Middle East (NAME) region, 1990-2019: a systematic analysis of the global burden of disease study.BMC Public Health. 2024 Feb 22;24(1):557. doi: 10.1186/s12889-024-18027-6. BMC Public Health. 2024. PMID: 38388875 Free PMC article.
Cited by
-
Circular RNAs: emerging players in asthma and COPD.Front Cell Dev Biol. 2023 Nov 24;11:1267792. doi: 10.3389/fcell.2023.1267792. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38078005 Free PMC article. Review.
-
Burden of chronic obstructive pulmonary disease attributable to non-optimal temperature, 1990-2044: six countries on the same isotherm.BMC Public Health. 2024 Dec 18;24(1):3407. doi: 10.1186/s12889-024-20622-6. BMC Public Health. 2024. PMID: 39695480 Free PMC article.
-
Prognostic Value of Apolipoprotein E in Predicting One-year Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2025 May 23;20:1639-1650. doi: 10.2147/COPD.S512096. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40433394 Free PMC article.
-
Cross-Sectional Survey of COPD Risk in Undiagnosed Adults in Saudi Arabia Using the Arabic COPD-PS.Int J Chron Obstruct Pulmon Dis. 2025 Aug 20;20:2905-2911. doi: 10.2147/COPD.S530064. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40860612 Free PMC article.
-
Circular RNAs as Biomarkers in the Diagnosis of Human Diseases.Adv Exp Med Biol. 2025;1485:211-226. doi: 10.1007/978-981-96-9428-0_14. Adv Exp Med Biol. 2025. PMID: 40886279 Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials